Serum amyloid A level is increased in neuromyelitis optica and atypical multiple sclerosis with smaller T2 lesion volume in brain MRI

Journal of Neuroimmunology

Volumn 259, Issue 1-2, 2013, Pages 92-95

  Yokote, Hiroaki ^a   Yagi, Yohsuke ^a   Watanabe, Yukiko ^a   Amino, Takeshi ^a   Kamata, Tomoyuki ^a   Mizusawa, Hidehiro ^b  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Barkhof criteria; Multiple sclerosis; Neuromyelitis optica; Serum amyloid A; T helper 17 cells; T2 lesion volume

Indexed keywords

SERUM AMYLOID A;

ADULT; ARTICLE; BLOOD SAMPLING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ASSOCIATION; EPILEPSY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; PANIC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSYCHOSOMATIC DISORDER; SPINAL CORD DISEASE; SPINAL CORD LESION; TENSION HEADACHE;

ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA; SERUM AMYLOID A PROTEIN; SPINAL CORD; TH17 CELLS; YOUNG ADULT;

EID: 84877627316     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.03.004     Document Type: Article

References (16)

1. Barkhof F., Filippi M., Miller D.H., Scheltens P., Campi A., Polman C.H., Comi G., Ader H.J., Losseff N., Valk J. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997, 120(Pt. 11):2059-2069.
2. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132:3329-3341.
3. Doi H., Matsushita T., Isobe N., Matsuoka T., Minohara M., Ochi H., Kira J.I. Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult. Scler. 2009, 15:304-310.
4. Domingues H.S., Mues M., Lassmann H., Wekerle H., Krishnamoorthy G. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One 2010, 5:e15531.
5. Durelli L., Conti L., Clerico M., Boselli D., Contessa G., Ripellino P., Ferrero B., Eid P., Novelli F. T-Helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann. Neurol. 2009, 65:499-509.
6. He R., Shepard L.W., Chen J., Pan Z.K., Ye R.D. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J. Immunol. 2006, 177:4072-4079.
7. Herges K., de Jong B.A., Kolkowitz I., Dunn C., Mandelbaum G., Ko R.M., Maini A., Han M.H., Killestein J., Polman C., Goodyear A.L., Dunn J., Steinman L., Axtell R.C. Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult. Scler. 2012, 18:398-408.
8. Ishizu T., Osoegawa M., Mei F.J., Kikuchi H., Tanaka M., Takakura Y., Minohara M., Murai H., Mihara F., Taniwaki T., Kira J. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005, 128:988-1002.
9. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., Tanoue T., Imaoka A., Itoh K., Takeda K., Umesaki Y., Honda K., Littman D.R. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
10. Lee E., Chanamara S., Pleasure D., Soulika A.M. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J. Neuroinflammation 2012, 9:7.
11. Lees J.R., Golumbek P.T., Sim J., Dorsey D., Russell J.H. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 2008, 205:2633-2642.
12. Migita K., Koga T., Torigoshi T., Motokawa S., Maeda Y., Jiuchi Y., Izumi Y., Miyashita T., Nakamura M., Komori A., Ishibashi H. Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes. Clin. Exp. Immunol. 2010, 162:244-250.
13. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
14. Ristori G., Laurenti F., Stacchini P., Gasperini C., Buttinelli C., Pozzilli C., Salvetti M. Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 1998, 88:9-12.
15. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., Watanabe S., Shiga Y., Kanaoka C., Fujimori J., Sato S., Itoyama Y. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
16. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.